GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » Current Ratio

Zenith Capital (Zenith Capital) Current Ratio : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Zenith Capital's current ratio for the quarter that ended in . 20 was 0.00.

Zenith Capital has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Zenith Capital has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Zenith Capital's Current Ratio or its related term are showing as below:

ZHCLF's Current Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.775
* Ranked among companies with meaningful Current Ratio only.

Zenith Capital Current Ratio Historical Data

The historical data trend for Zenith Capital's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital Current Ratio Chart

Zenith Capital Annual Data
Trend
Current Ratio

Zenith Capital Quarterly Data
Current Ratio

Competitive Comparison of Zenith Capital's Current Ratio

For the Biotechnology subindustry, Zenith Capital's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenith Capital's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenith Capital's Current Ratio distribution charts can be found below:

* The bar in red indicates where Zenith Capital's Current Ratio falls into.



Zenith Capital Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Zenith Capital's Current Ratio for the fiscal year that ended in . 20 is calculated as

Current Ratio (A: . 20 )=Total Current Assets (A: . 20 )/Total Current Liabilities (A: . 20 )
=/
=

Zenith Capital's Current Ratio for the quarter that ended in . 20 is calculated as

Current Ratio (Q: . 20 )=Total Current Assets (Q: . 20 )/Total Current Liabilities (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Capital  (OTCPK:ZHCLF) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Zenith Capital Current Ratio Related Terms

Thank you for viewing the detailed overview of Zenith Capital's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenith Capital (Zenith Capital) Business Description

Traded in Other Exchanges
N/A
Address
300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1
Website
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines